PI3K/Akt signaling also represents a potent and fundamental axis of signal relay that determines the basal survival and resistance to the apoptotic effects of chemo-radiotherapy in a variety of cancers, which makes PI3K/Akt pathway a central focus of mechanistic investigations in pancreatic cancer [13], [14]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.